Pharmacokinetics of the bicyclic peptide tachykinin NK2 receptor antagonist MEN 11420 in rats and guinea-pigs

被引：0
|
作者：
Lippi, A [1 ]
Criscuoli, M [1 ]
Santicioli, P [1 ]
Maggi, CA [1 ]
机构：
[1] Menarini Ric, Dept Pharmacol, Florence, Italy
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1998年 / 123卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
339P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Effect of several bicyclic peptide and cyclic pseudopeptide tachykinin NK2 receptor antagonists in the human isolated urinary bladder
    Giuliani, S
    Patacchini, R
    Lazzeri, M
    Benaim, G
    Turini, D
    Quartara, L
    Maggi, CA
    JOURNAL OF AUTONOMIC PHARMACOLOGY, 1996, 16 (05): : 251 - 259
  • [32] Effect of several bicyclic peptide and cyclic pseudopeptide tachykinin NK2 receptor antagonists in the human isolated ileum and colon
    Patacchini, R
    Giuliani, S
    Lazzeri, M
    Turini, A
    Quartara, L
    Maggi, CA
    NEUROPEPTIDES, 1997, 31 (01) : 71 - 77
  • [33] MEN 11,420, a peptide tachykinin NK2 receptor antagonist, reduces motor responses induced by the intravesical administration of capsaicin in vivo
    Lecci, A
    Giuliani, S
    Tramontana, M
    Criscuoli, M
    Maggi, CA
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (02) : 182 - 188
  • [34] TACHYKININ-MEDIATED RESPIRATORY EFFECTS IN CONSCIOUS GUINEA-PIGS - MODULATION BY NK(1) AND NK(2) RECEPTOR ANTAGONISTS
    KUDLACZ, EM
    LOGAN, DE
    SHATZER, SA
    FARRELL, AM
    BAUGH, LE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 241 (01) : 17 - 25
  • [35] MEN 11,420, a peptide tachykinin NK2 receptor antagonist, reduces motor responses induced by the intravesical administration of capsaicin in vivo
    A. Lecci
    Sandro Giuliani
    Manuela Tramontana
    Marco Criscuoli
    Carlo Alberto Maggi
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1997, 356 : 182 - 188
  • [36] Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist
    EmondsAlt, X
    Advenier, C
    Cognon, C
    Croci, T
    Daoui, S
    Ducoux, JP
    Landi, M
    Naline, E
    Neliat, G
    Poncelet, M
    Proletto, V
    VanBroeck, D
    Vilain, P
    Soubrie, P
    LeFur, G
    Maffrand, JP
    Breliere, JC
    NEUROPEPTIDES, 1997, 31 (05) : 449 - 458
  • [37] Involvement of tachykinin NK1 and NK2 receptors in substance P-induced microvascular leakage hypersensitivity and airway hyperresponsiveness in guinea-pigs
    Boichot, E
    Biyah, K
    Germain, N
    EmondsAlt, X
    Lagente, V
    Advenier, C
    EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (07) : 1445 - 1450
  • [38] Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor
    Meini, S
    Catalani, C
    Bellucci, F
    Cucchi, P
    Giuliani, S
    Zappitelli, S
    Rotondaro, L
    Pasqui, F
    Guidi, A
    Altamura, M
    Giolitti, A
    Maggi, CA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 516 (02) : 104 - 111
  • [39] A non-peptidic photoactivatable antagonist for mapping the antagonist binding site of the tachykinin NK2 receptor
    Kersey, ID
    Bhogal, N
    Donnelly, D
    Fishwick, CWG
    Findlay, JBC
    Ward, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (06) : 605 - 608
  • [40] The peripheral NK-1/NK-2 receptor antagonist MDL 105,172A inhibits tachykinin-mediated respiratory effects in guinea-pigs
    Kudlacz, EM
    Knippenberg, RW
    Shatzer, SA
    Kehne, JH
    McCloskey, TC
    Burkholder, TP
    JOURNAL OF AUTONOMIC PHARMACOLOGY, 1997, 17 (02): : 109 - 119
12345